|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| (11) | Number of the document | 2283866 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10010047.8 |
| Date of filing the European patent application | 2000-06-23 | |
| (97) | Date of publication of the European application | 2011-02-16 |
| (45) | Date of publication and mention of the grant of the patent | 2015-02-25 |
| (46) | Date of publication of the claims translation | 2015-08-25 |
| (30) | Number | Date | Country code |
| 141316 P | 1999-06-25 | US | |
| 189844 P | 2000-03-16 | US |
| (72) |
Erickson, Sharon, US
Schwall, Ralph, US
Sliwkowski, Mark X., US
Blattler, Walter Dr., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
Immunogen, Inc., 830 Winter Street, Waltham, MA 02451-1477, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gydymo būdai, naudojant anti- ERBB2 antikūno-maitanzinoido konjugatus |
| METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2019-06-18 | 20 | 347.00 EUR |